Eight experimental treatments and two vaccines for Ebola were on the table Thursday as 200 health experts met to discuss how to end the world's worst-ever outbreak of the killer virus.
Sep 4, 2014
0
0
An experimental vaccine to prevent the mosquito-borne viral illness chikungunya elicited neutralizing antibodies in all 25 adult volunteers who participated in a recent early-stage clinical trial conducted by researchers ...
Aug 14, 2014
0
0
Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work.
Aug 14, 2014
0
0
In the four decades since the Ebola virus was first identified in Africa, treatment hasn't changed much. There are no licensed drugs or vaccines for the deadly disease.
Aug 1, 2014
3
0
There is no vaccine on the world market to protect against the deadly Ebola virus, but experts say the fast-growing outbreak in West Africa is speeding efforts to test one.
Aug 1, 2014
1
0
An experimental vaccine designed to spur production of antibodies against a key malaria parasite protein, AMA1, was developed more than decade ago by scientists from the National Institute of Allergy and Infectious Diseases ...
Jun 23, 2014
0
0
Updated Phase 1/2a results with GEN-003, a vaccine candidate under development by Genocea Biosciences, Inc. for the treatment of herpes simplex virus type 2 (HSV-2) infection, showed the experimental vaccine to generate highly ...
Mar 25, 2014
0
0
(HealthDay)—The planned use of an experimental Neisseria meningitides serogroup B (MenB) meningitis vaccine at the University of Princeton has raised several contentious issues relating to vaccination, according to an ideas ...
Jan 5, 2014
0
0
Patients with recurrent glioblastoma multiforme (GBM) treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard ...
Dec 16, 2013
0
0
An experimental vaccine to protect against respiratory syncytial virus (RSV), a leading cause of illness and hospitalization among very young children, elicited high levels of RSV-specific antibodies when tested in animals, ...
Oct 31, 2013
0
0
